Exposure to cGMPs through CFR

Exposure to cGMPs through CFR

Join the Emerging Leaders committee and Lachmann Consultants as Frances Zipp discusses cGMPs as they are related to the Code of Federal Regulations Parts 210, 211 and 800. In this presentation, Fran will enhance your compliance vocabulary, break down the CFR 210/211 and 800 sections, and link GMP to real-world examples of enforcement examples by international regulatory authorities. The presentation will be fully virtual. This event is virtual only. 

Speaker:

Fran Zipp

President and CEO of Lachman Consultant Services, Inc.

Frances (Fran) M. Zipp is President & CEO of Lachman Consultant Services, Inc. Lachman Consultants provides compliance, regulatory and technical consulting services to the global pharmaceutical and related industries and Ms. Zipp delivers the strategic guidance and direction toward implementation of effective solutions to client needs. As an expert in compliance enhancement, she develops program solutions to meet GXP compliance requirements. Ms. Zipp has extensive experience in the pharmaceutical, biologic and biotechnology industries from R&D through post-market approval. She assists and counsels Senior-level management in areas of Corporate Governance, Corporate Integrity Agreement Compliance, Consent Decree Negotiations and Resolutions, Application Integrity Policy resolution, Due Diligence evaluations (facilities; products; technologies), and more. She was elected to the ISPE Board of Directors in 2013. 

Registration Information:

Register now!

Brought to you by the Emerging Leaders Committee (formerly YP Committee) but open to all!